AR090167A1 - Composicion farmaceutica cuyo principio activo es el modafinilo en su forma de enantiomero s presentandose como un jarabe - Google Patents
Composicion farmaceutica cuyo principio activo es el modafinilo en su forma de enantiomero s presentandose como un jarabeInfo
- Publication number
- AR090167A1 AR090167A1 ARP130100594A ARP130100594A AR090167A1 AR 090167 A1 AR090167 A1 AR 090167A1 AR P130100594 A ARP130100594 A AR P130100594A AR P130100594 A ARP130100594 A AR P130100594A AR 090167 A1 AR090167 A1 AR 090167A1
- Authority
- AR
- Argentina
- Prior art keywords
- pharmaceutical composition
- modafinil
- syrup
- mixture
- sugar
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1200579A FR2987265B1 (fr) | 2012-02-28 | 2012-02-28 | Composition pharmaceutique sous forme de sirop a base de modafinil, son procede de fabrication et son application |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR090167A1 true AR090167A1 (es) | 2014-10-22 |
Family
ID=48083445
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP130100594A AR090167A1 (es) | 2012-02-28 | 2013-02-27 | Composicion farmaceutica cuyo principio activo es el modafinilo en su forma de enantiomero s presentandose como un jarabe |
Country Status (4)
| Country | Link |
|---|---|
| AR (1) | AR090167A1 (fr) |
| FR (1) | FR2987265B1 (fr) |
| TW (1) | TW201340994A (fr) |
| WO (1) | WO2013128086A1 (fr) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5618845A (en) | 1994-10-06 | 1997-04-08 | Cephalon, Inc. | Acetamide derivative having defined particle size |
| US6489363B2 (en) | 2000-10-11 | 2002-12-03 | Cephalon, Inc. | Pharmaceutical solutions of modafinil compounds |
| US6919378B2 (en) | 2000-10-11 | 2005-07-19 | Cephalon, Inc. | Pharmaceutical solutions of modafinil compounds |
| PL215226B1 (pl) * | 2000-10-11 | 2013-11-29 | Cephalon | Kompozycja farmaceutyczna zawierajaca zwiazek modafinilu, sposób jej wytwarzania oraz jej zastosowanie |
| US7576133B2 (en) | 2002-03-11 | 2009-08-18 | Carl Henry Lawyer | Methods and compositions for nasal administration of modafinil |
| US20040116532A1 (en) * | 2002-09-13 | 2004-06-17 | Craig Heacock | Pharmaceutical formulations of modafinil |
| US20050008704A1 (en) | 2003-07-11 | 2005-01-13 | Ray Anup Kumar | Pharmaceutical composition for solubility enhancement of hydrophobic drugs |
| US20060024370A1 (en) * | 2004-07-29 | 2006-02-02 | Cephalon France | Modafinil oral lyophilizate |
| EP1891938A1 (fr) * | 2006-07-24 | 2008-02-27 | Cephalon France | Haute dose soluble oralement d'une forme de dosage lyophilisé. |
| US8173169B2 (en) * | 2007-07-11 | 2012-05-08 | Hikma Pharmaceuticals | Formulation and process for the preparation of modafinil |
-
2012
- 2012-02-28 FR FR1200579A patent/FR2987265B1/fr not_active Expired - Fee Related
-
2013
- 2013-02-25 TW TW102106510A patent/TW201340994A/zh unknown
- 2013-02-25 WO PCT/FR2013/000050 patent/WO2013128086A1/fr active Application Filing
- 2013-02-27 AR ARP130100594A patent/AR090167A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW201340994A (zh) | 2013-10-16 |
| WO2013128086A1 (fr) | 2013-09-06 |
| FR2987265A1 (fr) | 2013-08-30 |
| FR2987265B1 (fr) | 2014-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2019000431A1 (es) | Tetrahidro-pirido[3,4-b]indoles moduladores de receptores de estrógenos y usos de los mismos. (divisional solicitud 201700814) | |
| CL2020000747A1 (es) | Formulaciones de niraparib. | |
| CU20060153A7 (es) | Nueva forma cristalina v de agomelatina, procedimiento para su preparación y composiciones farmacéuticas que las contienen | |
| CL2015002145A1 (es) | Preparación, usos y formas sólidas de ácido obeticólico (divisional de solicitud n° 3475-2014) | |
| GT201300243A (es) | Derivados de ácido 3-fenilpropiónico ramificados y su uso | |
| CR20130617A (es) | Derivados de piridin-2(1h)-ona útiles como medicamentos para el tratamiento de trastornos mieloproliferativos, rechazo de trasplantes, enfermedades mediadas por el sistema inmune y enfermedades inflamatorias | |
| CO6710926A2 (es) | Compuestos de n-heteroarilo | |
| DOP2015000170A (es) | Compuestos químicos | |
| UY31922A (es) | Compuestos | |
| SV2017005412A (es) | Compuestos de 1-alquil-6-oxo-1,6-dihidropiridin-3-ilo y usos de los mismos | |
| AR079536A1 (es) | Granulos para preparaciones farmaceuticas, metodo y aparato para su produccion | |
| BR112015017251A8 (pt) | composições farmacêuticas compreendendo doadores de nitroxil, misturas e usos das referidas composições farmacêuticas | |
| CR20120549A (es) | Composiciones farmacèuticas que comprenden hidromorfona y naloxona | |
| DOP2012000279A (es) | Composiciones farmaceuticas que comprenden hidromorfona y naloxona | |
| CO6640305A2 (es) | Elaboración de gránulos sin activos y tabletas que comprenden los mismos | |
| BR112015030431A2 (pt) | formulação de liberação modificada | |
| BR112015010271A8 (pt) | produto de comicronização, processo para o preparo de um produto de comicronização, composição farmacêutica e seus usos | |
| BR112014009242A2 (pt) | nanossuspensão farmacêutica | |
| AR077987A1 (es) | Combinacion farmaceutica que comprende 6-dimetilaminometil-1-(3-metoxifenil)-ciclohexano-1,3-diol o 6-dimetilaminometil-1-(3-hidroxifenil)-ciclohexano-1,3-diol y un antiepileptico | |
| CO7170181A2 (es) | Nueva composición de alfentanilo para el tratamiento del dolor agudo | |
| CL2010001577A1 (es) | Uso de nifurtimox para preparar un medicamento util en el tratamiento de enfermedades causadas por giardias. | |
| ECSP13013095A (es) | Composición farmacéutica que comprende fexofenadina | |
| AR090167A1 (es) | Composicion farmaceutica cuyo principio activo es el modafinilo en su forma de enantiomero s presentandose como un jarabe | |
| EA201691693A3 (ru) | Комбинированный лекарстсвенный препарат в форме шипучих таблеток и способ его получения | |
| ES2403549R1 (es) | Co-cristales de agomelatina con formadores de co-cristales |